Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Sara Fernández-VillabrilleMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Francisco Baena-HuertaMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0009-0004-6155-811X
Laura Suárez-FernándezMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0009-0004-0835-7546
Elena NefyodovaLaboratory of Skeletal Cell Biology and Physiology (SCEBP), Skeletal Biology and Engineering Research Center (SBE), Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Paula CalvóMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Nerea González-GarcíaMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0009-0003-3918-1179
Helena Gil-PeñaRedes de Investigación Cooperativa Orientadas a Resultados en Salud, RICORS2040-Renal, 33011 Oviedo, Spain.ORCID 0000-0002-8790-1391
Carlos Gómez-AlonsoMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Cristina Alonso-MontesMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0000-0002-1248-2858
Manuel Naves-DíazMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0000-0003-0323-2870
Christa MaesLaboratory of Skeletal Cell Biology and Physiology (SCEBP), Skeletal Biology and Engineering Research Center (SBE), Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Natalia Carrillo-LópezMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0000-0002-4227-4144
Sara PanizoMetabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Funding
European Union PI23/00833, CP23/00058, CP23/00105FWO #G078923N, #G038224NGobierno del Principado de Asturias IDI/2021/000080, IDE/2024/000706, BP20-081Instituto de Salud Carlos III CP23/00105, CP23/00058, PI20/00753, PI22/00195, PI23/00833, RICORS2040-RENAL (RD21/0005/0019, RD24/0004/0006, RD24/0004/0016), FI23/00007, CD24/00095, CP23/00058, CP23/00105
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Bone and BonesKidneyPhosphorus, DietaryReceptors, G-Protein-CoupledThrombospondinsAnimalsMaleOsteoprotegerinRANK LigandRatsRats, WistarR-SpondinsSignal TransductionOsteoprotegerinPhosphorus, DietaryRANK LigandReceptors, G-Protein-CoupledR-SpondinsThrombospondinsleucine rich repeat containing G protein-coupled receptor 4osteoprotegerinparathyroid hormonephosphorusReceptor Activator of Nuclear factor Kappa-B ligandR-spondinstrabecular bone
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
High Dietary Phosphorus Impairs Bone Microarchitecture and Induces Alterations in the LGR4-R-Spondins Axis in Rats with Normal Renal Function. · full record | OpenQuestion